Traphaco JSC (HOSE:TRA)

Market Cap	3.10T
Revenue (ttm)	2.55T
Net Income (ttm)	223.57B
Shares Out	41.45M
EPS (ttm)	5,393.75
PE Ratio	13.89
Forward PE	n/a
Dividend	4,000.00 (5.37%)
Ex-Dividend Date	Dec 31, 2025

Volume	2,716
Average Volume	20,140
Open	73,500
Previous Close	74,500
Day's Range	73,500 - 74,900
52-Week Range	63,000 - 79,000
Beta	0.07
RSI	63.09
Earnings Date	Jan 30, 2026

About Traphaco JSC

Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. The company offers medical supplies; antipyretics; medicines for the hair, eyes, central neutral system, respiratory system, and liver; and other products. It is also involved in the production of medicines to treat human diseases, nutritional food products, and medicines derived from medicinal herbs; trading in medicines, pharmaceuticals, vaccines-biological products, chemicals,...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 1,670
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: TRA

Financial Performance

In 2024, Traphaco JSC's revenue was 2.35 trillion, an increase of 2.09% compared to the previous year's 2.30 trillion. Earnings were 206.83 billion, a decrease of -9.60%.